Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Ketosteril Sarcopenia Chronic Kidney Disease

Authors not listed

Huashan Hospital · 2024

Abstract

The investigators hypothesize that Ketosteril can improve sarcopenia in patients with renal disease without increasing the burden on the kidneys and causing deterioration of renal function. Therefore, this study intends to take patients with CKD stage 3-4 and sarcopenia as the research object, give Ketosteril intervention or not to patients on the base of low-protein diet, and clarify the clinical benefits of Ketosteril prescription for improving sarcopenia in patients with CKD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-31 MST

Cite this

APA
Anonymous. (2024). Ketosteril Sarcopenia Chronic Kidney Disease. <em>Huashan Hospital</em>. https://clinicaltrials.gov/study/NCT06329622
Vancouver
Anonymous. Ketosteril Sarcopenia Chronic Kidney Disease. Huashan Hospital. 2024.
BibTeX
@misc{anon2024Ketost, title = {Ketosteril Sarcopenia Chronic Kidney Disease}, author = {Anonymous}, journal = {Huashan Hospital}, year = {2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings